Over 75 Emerging Biotech Firms Adopting Veeva Basics for Efficiency Boost

Veeva Basics: A Game Changer for Emerging Biotechs



In the dynamic landscape of biotechnology, Veeva Systems has emerged as a critical partner for over 75 biotech companies that are leveraging its Veeva Basics software suite. Designed for companies aiming for rapid growth, Veeva Basics offers tailored tools that optimize clinical, regulatory, and quality processes—vital areas for biotech companies striving to bring innovative therapies to market.

Accelerating Growth and Efficiency


Veeva Basics allows biotech firms to streamline operations and reduce costs significantly. By providing standardized applications, these companies can get operational with industry-leading software in a matter of weeks. This transition marks a shift from disparate entry tools to comprehensive, top-tier solutions that facilitate scalability as firms expand.

Tailored Solutions for Unique Needs


Veeva Basics is particularly designed for fast-growing businesses, offering pre-configured and pre-validated solutions. This feature ensures rapid deployment, regardless of company size. Among its offerings are:

  • - Veeva CTMS Basics: This tool facilitates effective management of clinical trials, encompassing milestones, monitoring, registration, problem-solving, and site communication.
  • - Veeva Submissions Publishing Basics: This system aids in the creation, publication, and submission of regulatory applications from a single platform.

According to Steve Harper, the General Manager of Veeva Basics, the adoption of these solutions is bridging a gap in availability. “An increasing number of biotechs are enjoying the time, cost, and effort savings that Veeva Basics provides in North America and Europe,” he notes.

Real-world Impact and Testimonials


The feedback from industry insiders underscores the transformative power of Veeva Basics. Dr. Ian Hodgson, COO at Corbus Pharmaceuticals, hailed its significance, stating, “Veeva Basics represents a turning point as it enables smaller biotech firms to access modern, connected applications that were previously exclusive to larger players.” His company is in growth mode, and he expresses confidence in Veeva's ability to scale alongside them.

Joe Thornton, Associate Director of Clinical Operations at Scancell, shares, “As we expand our studies, Veeva eTMF Basics gives us greater control over our data and processes to ensure readiness for trials. Having a leading industry solution with pre-configured best practices will foster speed and innovation as we continue developing new immunotherapies.”

Moreover, Dr. Rebecca Deng, Associate Director of Regulatory Affairs and Quality Systems at Terns Pharmaceuticals, emphasizes the benefits of global support and training offered with Veeva Basics, noting how easily it leads to significant time and resource savings due to its straightforward deployment and validation processes.

The Future of Veeva Basics


Launched on the robust Vault platform, Veeva Basics applications facilitate the scaling of clients’ technological infrastructure in tandem with their growth. As of now, both Veeva CTMS Basics and Submissions Publishing Basics are available in North America and Europe.

For those interested in learning more about how Veeva Basics can revolutionize their operations, detailed information is available at veeva.com/VeevaBasics.

About Veeva Systems


Veeva is a leading provider of cloud software for the life sciences industry, committed to innovation, product quality, and customer success, serving over 1,000 customers ranging from the largest biopharmaceutical companies to emerging biotech firms. As a public benefit corporation, Veeva strives to balance the interests of all stakeholders involved, including customers, employees, shareholders, and the industries in which it operates.

For further inquiries, contact Jeremy Whittaker at Veeva Systems or refer to veeva.com/eu.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.